Avid Bioservices Inc (CDMO)
6.53
-0.18
(-2.68%)
USD |
NASDAQ |
Apr 18, 16:00
6.53
0.00 (0.00%)
After-Hours: 20:00
Avid Bioservices Net Income (Quarterly): -9.509M for Oct. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2023 | -9.509M |
| July 31, 2023 | -2.093M |
| April 30, 2023 | -0.309M |
| January 31, 2023 | 0.461M |
| October 31, 2022 | -1.156M |
| July 31, 2022 | 1.564M |
| April 30, 2022 | 115.60M |
| January 31, 2022 | 2.248M |
| October 31, 2021 | 3.522M |
| July 31, 2021 | 6.304M |
| April 30, 2021 | 1.991M |
| January 31, 2021 | 2.207M |
| October 31, 2020 | 2.284M |
| July 31, 2020 | 4.73M |
| April 30, 2020 | -4.768M |
| January 31, 2020 | -2.104M |
| October 31, 2019 | -0.43M |
| July 31, 2019 | -3.164M |
| April 30, 2019 | 0.336M |
| January 31, 2019 | -1.139M |
| October 31, 2018 | -1.451M |
| July 31, 2018 | -1.961M |
| April 30, 2018 | 3.02M |
| January 31, 2018 | -11.00M |
| October 31, 2017 | -12.62M |
| Date | Value |
|---|---|
| July 31, 2017 | -1.205M |
| April 30, 2017 | -5.272M |
| January 31, 2017 | -7.774M |
| October 31, 2016 | -4.056M |
| July 31, 2016 | -11.06M |
| April 30, 2016 | -11.88M |
| January 31, 2016 | -16.85M |
| October 31, 2015 | -13.20M |
| July 31, 2015 | -13.72M |
| April 30, 2015 | -12.14M |
| January 31, 2015 | -12.99M |
| October 31, 2014 | -12.10M |
| July 31, 2014 | -13.13M |
| April 30, 2014 | -10.25M |
| January 31, 2014 | -9.724M |
| October 31, 2013 | -7.79M |
| July 31, 2013 | -7.60M |
| April 30, 2013 | -8.449M |
| January 31, 2013 | -4.914M |
| October 31, 2012 | -8.753M |
| July 31, 2012 | -7.664M |
| April 30, 2012 | -10.88M |
| January 31, 2012 | -11.09M |
| October 31, 2011 | -12.06M |
| July 31, 2011 | -8.092M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-9.509M
Minimum
Oct 2023
115.60M
Maximum
Apr 2022
6.195M
Average
0.461M
Median
Jan 2023
Net Income (Quarterly) Benchmarks
| Emergent BioSolutions Inc | -49.50M |
| Creative Medical Technology Holdings Inc | -1.679M |
| Viking Therapeutics Inc | -24.60M |
| Stereotaxis Inc | -5.04M |
| MAIA Biotechnology Inc | -6.257M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 25.40M |
| Total Expenses (Quarterly) | 36.62M |
| EPS Diluted (Quarterly) | -0.15 |
| Enterprise Value | 534.06M |
| Gross Profit Margin (Quarterly) | -18.37% |
| Profit Margin (Quarterly) | -37.44% |
| Earnings Yield | -2.68% |
| Normalized Earnings Yield | -2.679 |